| Salmeterol (4/0) | Salsalate (2/0) | Samarium (1/0) |
| Saquinavir (6/0) | Sargramostim (3/0) | Scopolamine (5/0) |
| Secretin (1/0) | Selegiline (3/0) | Selenium (1/0) |
| Sermorelin (1/0) | Sertraline (6/0) | Sevelamer (3/0) |
| Sevoflurane (1/0) | Sibutramine (4/0) | Sildenafil (16/0) |
| Silver Sulfadiazine (1/0) | Simvastatin (5/0) | Sincalide (1/0) |
| Sirolimus (3/0) | Skin Graft (1/0) | Sodium Ferric Gluconate (1/0) |
| Sodium Fluoride (3/0) | Sodium Hyaluronate (4/0) | Sodium Phosphate Monobasic Monohydrate (1/0) |
| Sodium Polystyrene (1/0) | Sodium Sulfactemide (3/0) | Sodium Tetradecyl (1/0) |
| Somatrem (1/0) | Somatropin (4/0) | Sotalol (3/0) |
| Sparfloxacin (2/0) | Spectinomycin (1/0) | Spironolactone (2/0) |
| Stanozolol (1/0) | Stavudine (5/0) | Streptokinase (4/0) |
| Streptomycin (2/0) | Streptozocin (2/0) | Succimer (1/0) |
| Succinylcholine (2/0) | Sucralfate (2/0) | Sulfacetamide (3/0) |
| Sulfadoxine (1/0) | Sulfamethoxazole (2/0) | Sulfasalazine (2/0) |
| Sulfathiazole (1/0) | Sulfinpyrazone (2/0) | Sulfoxide (1/0) |
| Sulindac (2/0) | Sulphonamides (4/0) | Sumatriptan (4/0) |
SomatoKine
This site describes this drug candidate (rhIGF-1/IGFBP-3) and some of its therapeutic uses for which Insmed Incorporated is succesfully developing the candidate.
This site describes this drug candidate (rhIGF-1/IGFBP-3) and some of its therapeutic uses for which Insmed Incorporated is succesfully developing the candidate.
(Clicks: 9,317; Comments: 0; Added: 10-20-2006)
http://www.insmed.com/ProdPipeline.htm -
Details